NCT06470529

Brief Summary

In this retrospective cohort study, all patients from Iranian registry were recruited and follow up after 5 years were recorded for MACE, and its relation to type and demographic data were evaluated

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
4,159

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2019

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2019

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2021

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2021

Completed
3 years until next milestone

First Submitted

Initial submission to the registry

June 17, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 24, 2024

Completed
Last Updated

June 27, 2024

Status Verified

June 1, 2024

Enrollment Period

1.9 years

First QC Date

June 17, 2024

Last Update Submit

June 25, 2024

Conditions

Keywords

Percutaneous coronary interventionMajor adverse coronary events (MACE)drug eluting stents

Outcome Measures

Primary Outcomes (1)

  • Major adverse coronary events

    Total sum of Myocardial infarction (MI), Hospital admission, Death, reoperation or re PCI,

    5 years

Study Arms (1)

PCI

Post PCI patients with drug eluting stents

Device: drug eluting stents

Interventions

different types of drug eluting stents

PCI

Eligibility Criteria

Age36 Years - 82 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients all around the Iran, from 40 hospitals, who undergone PCI as elective or emergency patients

You may qualify if:

  • Patients with coronary angioplasty who received at least one type of DES

You may not qualify if:

  • Patients who received multiple types of stents
  • Patients who need emergency operation post PCI

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shiraz University of Medical Sciences

Shiraz, Fars, 713481433, Iran

Location

MeSH Terms

Conditions

Coronary Artery Disease

Interventions

Drug-Eluting Stents

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Intervention Hierarchy (Ancestors)

StentsProstheses and ImplantsEquipment and Supplies

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Target Duration
5 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
professor

Study Record Dates

First Submitted

June 17, 2024

First Posted

June 24, 2024

Study Start

March 1, 2019

Primary Completion

February 1, 2021

Study Completion

July 1, 2021

Last Updated

June 27, 2024

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will not share

Data was available based on rational request

Locations